We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

With eyonis™ we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Insights 科学发表

科学发表

06/04/2025

Al-assisted Lung Cancer Screening:Results from REALITY, a pivotalvalidation study of an Al/ML-based software

Presented at the American ThoracicSociety Congress in San Francisco

科学发表

Al-assisted Lung Cancer Screening:Results from REALITY, a pivotalvalidation study of an Al/ML-based software

欢迎订阅以接收影研新闻和相关活动的电子邮件通知。